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PERIODONTAL DISEASE SEVERITY-CORRELATION WITH DIABETES AND 
OBESITY MEASURES? 
MINA JASSAM 
ABSTRACT 
 This paper studies the correlation between three widely common chronic diseases, 
periodontal disease, diabetes, and obesity. The three diseases share one key factor; 
they not only affect human’s health but also the style and quality of life.  This paper 
evaluated the current literature regarding periodontal disease, diabetes, obesity, 
and their triangular relationship. The studies showed that the three chronic diseases 
are related to each other in a triangular relationship. Increased adiposity manifested 
by BMI greater than 30, leads to increased systemic inflammation through the 
release of inflammatory adipokines from the fatty deposits, this leads to the 
development of diabetes mellitus by different mechanisms, partly by destruction of 
the islet cells of Langerhans and partly by insulin resistance. One of the 
complications of diabetes mellitus is periodontal disease, which is a list of clinical 
conditions that adversely affect the health of the periodontium. Moreover, current  
literature provides evidence that the relationship between diabetes and periodontal 
disease is bidirectional. Evidence from current studies is showing that periodontal 
disease might lead to the development of diabetes by increasing the systemic 
inflammation, this occurs by the invasion of periodontal pathogens of the 
endothelial cells where they elicit an exacerbated systemic inflammation which 
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might lead to the development of diabetes and other chronic conditions. This paper 
shows the importance of collaborative work between the dental and the medical 
professionals to ensure the overall health of an individual. Primary care physicians 
are encouraged to refer patients with poor glycemic control to dentists for an 
assessment of the health of their oral cavity and vice versa; dentists should be more 
aware of the systemic complications of oral diseases and should educate their 
patients about such relationships. 
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INTRODUCTION 
 
 Diabetes is a widely common systemic morbidity in today’s world in both 
developing and developed nations. Recently many studies have investigated not 
only the role of obesity in diabetes but also if a causative correlation exists between 
obesity, diabetes and the progression of periodontal disease.  This study aims to 
provide evidence for an underlying mechanism linking diabetes, obesity and 
periodontal disease. 
 
Diabetes 
 Diabetes Mellitus (DM) is a global epidemic whose complications impact the 
quality of life significantly (Figure 1) (1). Moreover, diabetes affects longevity and 
health care costs (2). Diabetes is one of the top ten leading causes of death in most 
world-wide (Figure 2) and the 7th in developed countries and it is an endemic in 
many developing and newly industrialized nations (3).   
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Figure 1: Prevalence of Diabetes World-Wide.  Shown is the prevalence relative 
to population and morbidity levels for 2000 and projected for 2013.  Figure 
downloaded from Globalist Report (1).  
 
 
Figure 2: Prevalence of Diabetes World-Wide.  Shown is the prevalence for 2011.  
Figure downloaded from WHO International – The Top 10 Causes of Death (2).  
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The World Health Organization (WHO) predicts there will be an increase in 
the number of people with diabetes from 347 to 439 million by 2030 (4). In the 
United States, 8.3% of the population has diabetes including 25.8 million children 
and adults. There are 215,000 people under the age of 20 have diabetes; about 1 in 
every 400 children or adolescents has diabetes, 25.6 million people who are 20 and 
older have it and 10.9 million people who are 65 or older have it. The total number 
of men and women with diabetes  is 13 million and 12.6 million respectively (5). 
 There are important differences in the prevalence of diabetes among 
different races and ethnicities; diabetes affects 7.1% of non-Hispanic whites, 8.4% of 
Asian Americans, 12.6% of non-Hispanic blacks, 11.8% of Hispanics. Among 
Hispanics rates were, 7.6% for Cubans, 13.3% for Mexican Americans, and 13.8% 
for Puerto Ricans (Figure 3)(6) . This escalating problem necessitates the 
development of preventive and therapeutic measures to manage this growing 
disease and its complications. Diabetes is preceded by an inflammation in the body, 
which will eventually lead to the apoptosis of pancreatic beta cells, and the 
development of insulin resistance (7). Therefore any condition that contributes to 
systemic inflammation (for example obesity) will exacerbate the complications of 
diabetes.    
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Figure 3:  New Cases of Type 1 and Type 2 Diabetes among Youth Younger than 
20 Years Old from 2002-2005.  Shown is the rate of new cases y race and 
ethinicity among the following groups: NHW=non-Hispanic whites; NHB=non-
Hispanic blacks; H=Hispanics/Latinos; API=Asian/Pacific Islander Americans; 
AI=American Indians.  Figure taken from NIDDK- National Diabetes Statistics 2011 
(7). 
 
  DM is a metabolic disease that is characterized by high blood glucose levels 
due to insufficient amount of insulin secreted by beta cells or due to insulin 
resistance in which insulin target cells do not respond to the insulin produced (8). 
DM has many symptoms including polyuria which is frequent urination, polydipsia 
or excessive thirst , unexplained weight loss, polyphagia which is extreme hunger, 
sudden vision changes, tingling or numbness in the hands or feet, feeling very tired 
much of the time, very dry skin, sores that are slow to heal, more infections than 
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usual. Some people may experience some of the symptoms listed above but others 
might not experience any and might not know they are diabetic until their blood 
sugar reaches very high levels (9).  
There are three main types of DM, Type 1 which was previously called 
juvenile DM and is insulin dependent.  Type 1 DM is usually diagnosed in children 
and young adults, only 5% of the total diagnosed people with diabetes have Type 1 
(10). Patients with this type of DM do not produce insulin which is necessary for 
glucose uptake into the cells. It is also classified as an autoimmune disease, as it 
occurs through activation of auto-aggressive T cells that are thought to mediate 
destruction of beta cells in the pancreas. Thus insulin is no longer secreted, it is 
multi-factorial involving a genetic predisposition [11] and environmental triggers 
[12] such as viruses.  Several studies have shown the concordance rate for the 
development of Type I DM among monozygotic twins is no more than 50% which 
shows that Type I DM is not exclusively genetic and that other factors can come into 
play. Although imperfectly understood, environmental challenges may contribute to 
accelerating or triggering autoimmune diseases in genetically predisposed people 
(13). Many studies showed that viral infections are powerful events in triggering 
Type 1 DM, they do this by breaking the tolerance against self antigens so the body 
starts destroying its own cells. This occurs by three different mechanisms: (i) by 
inducing virus-mediated cell damage of target organs directly or via secretion of 
inflammatory cytokines that specifically harm beta cells, (ii) by enhancing function 
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of antigen presenting cells (APCs) leading to increased presentation of autoantigens 
and/or (iii) by molecular mimicry, where immunity against viral antigens cross-
reacts with self-antigens that are exhibiting a conformationally similar structure ( 
14).  Evidence from several mouse and human models show that Type I DM is a T-
cell mediated autoimmune disease.  From autopsies of pancreata of patients who 
recently died from sudden onset of Type I DM it was demonstrated that there was 
an  infiltration of lymphocytes and macrophages with high proportion of CD8+ cells, 
which are a type of cytotoxic T cells that destroy virally infected and tumor cells. 
They express the CD 8 glycoprotein on their surface (15).  A schematic illustrating 
the pathogenesis of Type I DM is shown below in Figure 4. 
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Figure 4. Pathogenesis of Type 1 Diabetes Mellitus. Schematic model showing 
infiltration and destruction of the islets of Langerhans over the time. At least three 
factors might be involved in the destruction of beta cells. Genetic susceptibility is 
required to create a fertile environment for T1D development, several 
environmental factors might trigger the pathogenesis and precipitate the pre-
diabetic phase (factor 2). Lastly, destruction of insulin-producing beta cells by 
sufficient numbers of infiltrating autoaggressive T cells leads to overt diabetes 
(factor 3). Counter-regulation of autoaggression by autoreactive regulatory T cells 
might be capable of preventing destruction of all beta cells even late during disease. 
Figure taken from Drug Discovery Today: Disease Mechanisms (12). 
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Type II DM is characterized by hyperglycemia, insulin resistance and relative 
insufficient insulin secretion (Figure 5). The fact that it is a genetic disease was 
known to clinicians a long time ago, but a genetic predisposition is not the only 
cause of Type II DM (16). Our current life style has definitely a great deal to do with 
it, the high calorie intake, and the low expenditure of energy along with the 
sedentary life style is all leading to the development of diabetes through obesity, 
which will be further explained later on in the paper.  Understanding the 
pathological mechanism of development Type II DM is a complex process but Type 
II diabetic patients usually present varying degrees of insulin resistance and insulin 
deficiency and it is usually the combination of both that lead to the development of 
the disease. Insulin secretion by beta cells requires glucose transport into the cell, 
which is at least in part mediated by the glucose transporter 2 (GLUT-2). A mouse 
model with a genetic alteration affecting GLUT-2 expression produced mice with 
glucose intolerance; similar changes in GLUT-2 could be induced in normal mice fed 
a high-fat diet (17) and suggests a possible mechanism for the link between high-fat 
diet and the development of diabetes. Impaired insulin secretion in mice was also 
shown in those that lack Abca1, which is a cellular cholesterol transporter. Mice 
with inactivated Abca 1 in their beta cells have defective insulin secretion and 
impaired glucose tolerance (18). 
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Figure 5:  Pathogenesis of Type 2 Diabetes Mellitus   Shown is a schematic 
demonstrating the pathogenesis of DM and its predisposion with respect to genetic 
and environmental factors. Figure taken from Greevenbroek et al., 2013 (7).  
               
 People with Type 2 diabetes often have no symptoms at first. They may not 
have symptoms for many years. Early symptoms of diabetes may include: bladder, 
kidney, skin, or other infections that are more frequent or heal slowly, fatigue, 
hunger, increased thirst, increased urination, the first symptom may also be; blurred 
vision, erectile dysfunction, pain or numbness in the feet or hands (19).  The goal of 
treatment of Type II diabetes is to lower the blood glucose levels and in the long 
term to prevent any complications that may arise from diabetes, like blindness, 
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amputations due to gangrenes and kidney disease (20). The most important way to 
treat and manage Type II diabetes is nutrition, weight management and activity. 
Diabetics need to check their blood glucose level regularly or at least twice a day, 
they should know what to eat and when to eat it and if nutrition, activity and weight 
control fail to drop their blood glucose levels down, they can take medications like 
alpha-glucosidase inhibitors, biguanides, DPP IV inhibitors, injectable medicines, 
meglitinides, sulfonylureas and thiazolidinediones (21).  
 
Obesity 
Obesity is one of the major risk factors for diabetes besides genetic 
predisposal (22). Worldwide, at least 2.8 million people die from associated 
conditions each year as a result of being overweight or obese, and an estimated 35.8 
million (2.3%) globally (23).  Overweight and obesity are defined according to the 
WHO (World Health Organization) as excessive or abnormal fat accumulation that 
affects an individual’s health negatively (24). Overweight and obesity are major risk 
factors for a number of chronic diseases, including diabetes, cardiovascular diseases 
and cancer and while it was once an issue only in high-income countries, overweight 
and obesity has now dramatically risen in low- and middle-income countries (25). 
Such countries are now facing a "double burden" of disease, for while they continue 
to deal with the problems of infectious disease and under-nutrition, they are also 
experiencing a rapid upsurge in chronic disease risk factors such as obesity and 
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overweight, particularly in urban settings. Obesity is measured by the BMI which is 
weight to height ratio, it is the person’s weight in Kilograms divided by the square 
height in meters (Figure 6) (26). 
The WHO defines an adult who has a BMI between 25 and 29.9 as 
overweight - an adult who has a BMI of 30 or higher is considered obese - a BMI 
below 18.5 is considered underweight, and between 18.5 to 24.9 a healthy 
weight. In 2008, 35% of adults aged 20+ were overweight (BMI ≥ 25 kg/m2) 
(34% men and 35% of women) (Figure 6). The worldwide prevalence of obesity 
has nearly doubled between 1980 and 2008. In 2008, 10% of men and 14% of 
women in the world were obese (BMI ≥30 kg/m2), compared with 5% for men 
and 8% for women in 1980. An estimated 205 million men and 297 million 
women over the age of 20 were obese – a total of more than half a billion adults 
worldwide. 
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Figure 6:  Various Stages of Weight and Obesity With Respect to Height. 
(CDC, fact sheets, 2012) 
 
The prevalence of overweight and obesity were highest in the WHO Regions 
of the Americas (62% for overweight in both sexes, and 26% for obesity) and lowest 
in the WHO Region for South East Asia (14% overweight in both sexes and 3% for 
obesity). In the WHO Region for Europe and the WHO Region for the Eastern 
Mediterranean and the WHO Region for the Americas over 50% of women were 
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overweight. For all three of these regions, roughly half of overweight women are 
obese (23% in Europe, 24% in the Eastern Mediterranean, 29% in the Americas). In 
all WHO regions women were more likely to be obese than men. In the WHO regions 
for Africa, Eastern Mediterranean and South East Asia, women had roughly double 
the obesity prevalence of men (27).  
Comorbidities 
Overweight and obesity lead to adverse metabolic effects on blood pressure, 
cholesterol, triglycerides and insulin resistance (WHO, GHO, web).   Obesity 
contributes to numerous and varied comorbid conditions. Complications can occur 
in many organ systems, ranging from cardiovascular to respiratory to orthopedic 
and even ophthalmologic. Overweight and obesity are known risk factors for heart 
disease, diabetes, hypertension, gallbladder disease, osteoarthritis, sleep apnea and 
other breathing problems, and some cancers (uterine, breast, colorectal, kidney, and 
gallbladder) (28). In addition, obesity is associated with pregnancy complications, 
high blood cholesterol, menstrual irregularities, hirsutism (excessive hair growth), 
stress incontinence, psychological disorders, and increased surgical risk (29). Social 
discrimination against obese persons has a strong negative effect on their quality of 
life although it was viewed before as a symbol of wealth and fertility, nowadays it is 
stigmatized by people, and was considered a disease by the World Health 
Organization in 2013.  
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Since obesity leads to increased systemic inflammation and it has already 
been established that DM is associated with increased inflammation, both of these 
chronic conditions are interlinked and it is thought that increased obesity 
contributes to excessive systemic inflammation and thus DM.  
Periodontal Disease 
 Periodontology originated from the Greek, they used to call it peri-odous-
logos which means around the tooth discourse so the word periodontal literally 
means around the tooth and it consists of gingiva, cementum, periodontal ligament 
and alveolar bone (Figure 7). The periodontium starts from the col, which is the tip 
of the facial interdental papilla and it goes all the way to the trabecular bone which 
is the cancellous bone (30). Therefore, the common name periodontal disease is a 
misnomer because the periodontium consists of many structures so there is no one 
periodontal disease instead it is several clinical conditions affecting different 
structures and thus we use the term periodontal diseases. 
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Figure 7: Structure of the Periodontium, The periodontium: schematic drawing of 
the periodontium with all of its different components. The periodontium: schematic 
drawing of the periodontium with all of its different components. Figure taken from 
http://mouafaqbtc.com/articles/diseases-of-periodontal-ligament/ 
 
 
Periodontal disease is an infection caused by microorganisms that colonize 
tooth surface at or below the gingival margin. It is estimated that there are over 700 
species that are capable of colonizing the periodontium or the oral cavity in general 
and the average individual may typically harbor 150 or more different species (31). 
The microbial organisms that cause periodontal diseases reside in biofilms that 
subsist on the tooth surface or the surrounding epithelial surfaces. The biofilms are 
defined as matrix enclosed bacterial populations that are adherent to each other and 
to other surfaces. Our manifestation of infectious diseases comes from the common 
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infections people get like skin and upper respiratory infections and those usually 
show symptoms immediately at the site of infection or elsewhere. The tissues begin 
to shed if it’s a skin infection and if it’s an infection of the mucous membranes a 
constant battle between the organism and the host occurs and the body’s immune 
system usually overcomes the infection in favor of the host. Other systemic 
infections do not necessarily show symptoms but they are there, like for example 
those of Mycobacterium tuberculosis.  This organism colonizes 5% of Americans but 
only 2.6 per 100 000 new born individuals are reported each year (32).  Those 5% 
of the population are carrying the organism but not showing any symptom of the 
disease. In a similar fashion, an individual can be colonized by periodontal 
pathogens at any given time but might not show signs of any of the periodontal 
diseases and on the contrary to the common diseases that were described above, the 
unique feature about periodontal disease is that the tooth is a mineralized tissue so 
no shedding occurs or immediate signs that can be manifested. Instead the 
pathological process of periodontal diseases is a complex series of events (Figure 
8)(33).  First the organism must successfully colonize the periodontium, this 
happens by using adhesins on their surfaces such as fimbrae resulting in adherenece 
to the periodontium structures or other organisms there. They also have to resist 
being displaced by the flow of saliva, speech and the mouth movement during 
mastication. After adhering successfully to these structures, they coaggregat  and 
multiply and develop characteristics that evade the host’s immune responses. As 
those pathogens grow and develop they produce toxins that destroy the host’s 
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tissues or cause an inflammatory reaction in the oral cavity that causes destruction 
of the periodontium. Those virulence factors include enzymes like collagenases, 
substances that damage tissue cells like hydrogen sulfide and substances that cause 
cells to produce biologically active substances like lipopolysaccharides (34). So if a 
mild periodontal disease like gingivitis persists and propagates into deeper tissues 
of the periodontium, this will lead to deeper tissue destruction, loss of gingival 
attachment, pathologic alteration of cementum and periodontal ligament and 
destruction of alveolar bone, this condition is known as periodontitis. 
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Figure 8: Healthy and Diseased Periodontium. Shown are both the appearance of 
health gum as well as the build-up of plaque, tartar and increase pocket depth in 
diseased gum. Figure taken from http://naturessmile.com/about.php 
 
In contrast to obesity and diabetes it is difficult to epidemiologically interpret 
the prevalence of periodontal disease worldwide due to inconsistencies in the 
methodology used for evaluation (35). However, the American Dental Association 
(ADA) stated in a recent survey that roughly half of American adults aged 30 or 
older have some form of periodontal disease, according to Centers for Disease 
Control and Prevention (CDC) survey data reported Aug. 30. 2012 (36, ADA, 2012). 
An estimated 47.2 percent, or 64.7 million American, have mild, moderate or severe 
periodontitis, or gum disease, according to an analysis of data collected as part of 
CDC’s 2009-2010 National Health and Nutrition Survey. Prevalence rates increase to 
70.1 percent for adults 65 and older. The data also indicate certain prevalence 
disparities with respect to race and gender. Periodontal disease is higher in men 
than women, 56.4 and 38.4 percent respectively and highest in Mexican-Americans, 
66.7 percent, compared to other races. The prevalence rate is 64.2 percent for 
current smokers, 65.4 percent for adults living below the federal poverty level and 
66.9 percent for adults with less than a high school education. (37,Center for Disease 
Control and Prevention (CDC), 2012).  
Periodontal disease is diagnosed by probing the gums;  a pocket depth 
greater than 5 mm with bleeding on probing indicate that there is disease (Figure 
9). 
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Figure 9:  Probing Depth is a Method for Diagnoses of Periodontal Disease. 
Shows a periodontal probe being used to determine the pocket depth of a patient. 
Patient is bleeding on probing which is a sign of periodontal disease, Figure taken 
from http://www.spadental.co.uk/blog/2013/08/all-about-gum-disease/ 
 
 
Periodontal disease is treated by scaling and root planning, or by periodontal 
surgery if it was more advanced. It is also treated by eliminating the causes of it, for 
example if the patient smokes, the patient should be encouraged to quit and can be 
sent to rehab facilities for help. Moreover, for patients taking certain drugs that may 
affect the periodontal health such as the calcium channel blocker  nifedipine for 
cardiovascular problems, their primary care provider should be contacted and be 
asked for the possibility of switching to another alternative(38).  
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Diabetes and Obesity:  
One of the most important factors that contribute to diabetes is obesity. It 
has been known that increased adiposity leads to Type II diabetes for over a 
century; additionally,  epidemiological studies demonstrated a parallel increase in 
both obesity and Type II diabetes indicating the positive correlation between the 
two (39). Systemic body conditions associated with an increased body weight and 
specifically adiposity are well known by now due the enormous amount of studies 
that were done on that topic (40). It has been estimated that obese people have 
more than a ten-fold increased risk of developing Type II diabetes compared with 
normal weight individuals and one study has put increased risk for women with a 
BMI of 35 or greater at 93 fold. (41). During the last 15 years research has focused 
on unraveling the underlying biochemical mechanism linking adiposity with Type II 
diabetes which will be discussed and presented in the results. Ever since the 1950s 
the term metabolic syndrome became more and more common, Dr. Jean Vague first 
observed it in 1947 who concluded that upper body obesity predisposes individuals 
to diabetes, atherosclerosis and gout. Metabolic syndrome is a disorder of energy 
storage and utilization that is diagnosed when three or more of the following 
medical conditions co-occur in an individual; abdominal obesity, high blood 
pressure, high fasting plasma glucose, elevated serum triglycerides, and low high-
density cholesterol (HDL) levels. Metabolic syndrome is also called insulin 
resistance syndrome, this is mainly because in people with large fat deposits, they 
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have increased amounts of free fatty acids (FFA) in their circulation and this is the 
main factor that causes insulin resistance.  FFA cause insulin resistance  by 
inhibiting insulin mediated glucose uptake into the tissues and so this increases the 
serum plasma glucose levels. High plasma glucose levels will increase insulin 
production from the pancreas and so the individual will have hyperinsulinemia. In 
the liver, FFA increase the production of glucose, triglycerides and secretion of very 
low density lipoproteins (VLDL). The consequence is the reduction in glucose 
transformation to glycogen and increased lipid accumulation in triglyceride (TG). 
Insulin is an important antilipolytic hormone. In the case of insulin resistance, the 
increased amount of lipolysis of stored triacylglycerol molecules in adipose tissue 
produces more fatty acids, which could further inhibit the antilipolytic effect of 
insulin, creating additional lipolysis. 
Figure 10 shows the effect of insulin on various body organs. Insulin 
decreases overall glucose output in the liver and also increases lipogenesis. In 
skeletal muscle, it increases the formation of glycogen and increases glucose uptake. 
In adipocytes, it decreases lipolysis and increases lipogenesis.  So the overall effect 
of insulin is to promote glucose uptake and lipogenesis, also to prevent lipolysis. 
Insulin resistance causes accumulation of glucose in blood and enhances the 
production of more insulin from the pancreas, but because of the increased FFA, 
resistin and cytokines like Tumor Necrosis Factor alpha and interleukin 1, insulin 
signaling pathway is disrupted and insulin resistance develops. The exact 
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pathophysiology of insulin resistance is still not known unfortunately but there have 
been many studies in the literature that investigated the correlation between DM 
and obesity and almost all of them showed that there is an association between the 
two clinical conditions. Research done by National Institute of Diabetes, Digestive 
and Kidney Diseases (NIDDK) on Pima Indians who are genetically predisposed to 
obesity and Type II DM, showed that obesity is a major risk factor for the 
development of diabetes (42). There are two genetically identical Pima populations, 
one settled in southern Arizona and the other in a relatively remote region of 
Mexico.  The study found that as a group, the U.S. Pima Indians had more sedentary 
lifestyles and easier access to higher-calorie processed foods than the Mexican Pima 
Indians, who exhibited higher activity levels and consumed lower-fat, traditional 
foods. For this latter population, obesity was uncommon and the prevalence of 
T2DM was comparable to the U.S. population as a whole. However, strikingly, nearly 
half of the U.S. Pima population was found to have T2DM and of these, 
approximately 95% were obese (43). These findings support the idea that people 
who are more obese and follow an unhealthy sedentary life style are more prone to 
developing Type II DM.                      
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Figure 10:  The Effect of Insulin Throughout the Body .   Figure taken from 
Introduction to Insulin Activities from 
http://themedicalbiochemistrypage.org/insulin.php. 
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Oral Health and Obesity: 
Moreover, science and culture completely changed the way they view 
obesity. Chronic food shortage and malnutrition have been the scourge of 
humankind from the dawn of history. The current worldwide epidemic of obesity is 
only few decades old, that was probably defined as such only in the second half of 
the 19th century(44). The scarcity of food throughout history has led to the 
connotation that being fat is favorable, it was a sign of wealth, abundance and good 
health as defined in many books of literature, art and that was the medical opinion 
at that time. Advances of technology of the eighteenth century have solved this 
problem and nowadays people have an overabundance of food, technology not only 
solved the scarcity of food issue but also completely changed people’s lifestyles. Jobs 
that required physical activity no longer exist as everything became computerized 
or new machinery developed to replace such jobs, people’s lifestyles became more 
sedentary which led to them gaining weight and increased their BMI. People at the 
time did not know the consequences of such weight gain. Only in the latter half of 
the 19th century obesity was stigmatized for aesthetic reasons and in the 20th 
century its association with increased mortality was recognized. What has made this 
gradual medicalization of obesity alarming is the exponential increase in its 
incidence over the past 60 years, which led the WHO to declare it a global epidemic 
and worldwide public-health crisis(45). Over the past decades obesity was 
associated with heart disease, diabetes, hypertension and many other chronic 
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diseases as mentioned above in the obesity subsection. Recently, it is being linked to 
dental health as well, mainly periodontitis. However, studies examining the 
association between obesity and oral health yielded conflicting results, some 
showed an association between the two clinical conditions and for others the 
statistical correlation of such findings were limited to a certain age group; younger 
adults or even were not significant. When tooth loss was examined and its 
relationship with obesity, the results were more uniform. It can be concluded that as 
the number of missing teeth increases, the body mass index (BMI) increases. Fewer 
studies were done on the relationship between obesity and dental caries and the 
overall dental health in general. Again conflicting results were gained, obesity could 
not be a predictor of whether the person would have caries but in general poorer 
dental health was associated with people with higher BMIs. The relationship 
between obesity and oral health is bidirectional, bad oral health and more missing 
teeth affect the quality of food a person can eat, and usually nutrient rich food is 
replaced with softer, carbohydrate dense type of food which worsens the oral health 
of an individual even more. Also, people who are obese, usually have an imbalanced 
diet that is rich in sugar and saturated fat which offers a favorable environment for 
cariogenic bacteria to thrive in the oral cavity, such as lactobacilli and mutans 
streptococci, which eventually leads to the development of carious lesions. 
Moreover, obesity has been also linked to suppressed immune response and lead to 
the development of infectious diseases like periodontitis (46).  
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Obesity influences unspecific and specific immune responses mediated by 
humoral and cell mediated mechanisms (47). Unfortunately, the exact molecular 
and cellular mechanisms linking adiposity and immunity are still not known in 
details, however evidence from clinical and epidemiological data support the 
hypothesis that incidence and severity of several infectious diseases are higher in 
people who are obese than those who are lean, this has been manifested as a poor 
antibody response to antigens in people whose BMIs are higher than 30. Moreover, 
findings from Gottschlich and coworkers showed that the incidence and severity of 
infectious diseases amongst burn patients were higher in obese individuals than 
lean ones.  Thus the ratio of patients who developed bactraemia and sepsis was 
more in obese patients (9 out of 15), versus (2 out of 15) in the lean controls (Figure 
11). The antibiotic therapy was required for twice as many days for the obese 
patients than the lean controls but those results were not statistically significant.  
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Figure 11:  The Effect of Complications and Recovery time in Obese and Non-
Obese Patients.   Difference between obese and non-obese burn patients at 
developing sepsis and other bacterial infections . Figure shows that obese 
patients are at higher risk of developing infections and tend to stay longer in 
hospitals than their non-obese counterparts. Figure taken from NIH Public 
Access. Medical and Financial Risks Associated with Surgery in the Elderly 
Obese. April 2011. 
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SPECIFIC AIMS 
It is known that diabetes has an effect on the condition of the periodontium 
and often contributes to the progression of periodontal disease. Also periodontal 
disease leads to worsened glycemic control by increasing the inflammatory status of 
the body and thus leads to uncontrolled diabetes. Obesity is another global health 
problem which is associated with several systemic comorbidities as well, such as 
diabetes, cardiovascular disease, cancer, gall stones…etc (48). As a result excessive 
obesity leads to diabetes which has been shown to be correlated to periodontal 
disease. In this study we aim to provide evidence for an underlying mechanism 
linking diabetes, obesity and periodontal disease by studying the relationship and 
interactions of these three systemic conditions and eventually gain an 
understanding of what is currently called a triangular relationship.  
In addition to this, we aim to highlight to dental practitioners the importance 
of prevention and treatment of periodontal disease and the role they play in helping 
to reduce the burden of related systemic diseases. We hope that this study will 
clarify the relationship between diabetes and obesity with respect to periodontal 
disease. 
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PUBLISHED STUDIES 
Adipose tissue is no longer considered as merely a depository of fat 
containing cells; it is now seen as an active endocrine organ with adipocytes, like 
many other cells, capable of releasing hormones, the best known being leptin, the 
appetite controlling hormone and cytokines. These small proteins with a typical 
molecular weight in the range 8,000– 40,000 (49), which are related not by 
structure but by their common cellular signaling action, including the regulatory 
mechanism that determines the body’s reaction to cellular trauma and infection by 
either promoting or suppressing the inflammatory response (50). The cytokines 
secreted from the adipocytes are called adipokines and are secreted into the blood 
circulation where they mediate an inflammatory activity in the body system. The 
adipokines that show a proinflammatory action are Tumor Necrosis Factor alpha 
(TNF-a) and Interleukin (IL)-6 (IL-6) (51). Excessive secretion of adipokines is 
linked to the pathogenesis of diabetes. Thus excessive obesity can cause systemic 
inflammation and can mediate diabetes. This is because the increased circulating 
inflammatory chemokines, cytokines and adipokines disrupt insulin signaling in 
tissues like the liver and skeletal muscle and lead to insulin resistance and the onset 
of diabetes mellitus. While this evidence does not establish a causal relationship, the 
epidemiological data showing a parallel rise in obesity and Type 2 diabetes 
prevalence, both accompanied by raised levels of circulating pro-inflammatory 
cytokines, reinforces the belief in an inflammatory mediated metabolic mechanism 
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(52). The mechanism that is generally accepted to show causality is that a high 
calorie diet leads to accumulation of fatty acids in adipose tissue induces adipocyte 
hypertrophy and increases the production of reactive oxygen species (ROS) leading 
to the activation of adipose tissue inflammation and increased expression of 
cytokines (53). Upregulation of cytokines stimulates the infiltration of chronic 
inflammatory cells such as macrophages. These cells further accelerate 
inflammation by secreting more pro-inflammatory cytokines and chemoattractants 
(chemokines) causing further infiltration of chronic inflammatory cells and a further 
rise in pro-inflammatory adipokine secretion, thus initiating a self- generating 
reciprocal cycle of chronic inflammation (54). Increased levels of circulating free 
fatty acids, reactive oxygen species and inflammatory cytokines disrupt insulin 
signaling in organs such as skeletal muscle and the liver, leading to βcell 
dysfunction, systemic insulin resistance and the onset of diabetes mellitus (55). This 
was known because adipokines and adiposity were mirrored in the increase, 
circulating adipokines were found in higher concentrations in people with Type II 
diabetes (56).  
Chronic Inflammatory Periodontal Diseases 
Chronic inflammatory periodontal diseases are the most common 
inflammatory conditions among humans; periodontitis affects approximately 50% 
of adult population. (57) In persons with periodontitis the inflammatory response is 
responsible for destroying host tissue, which leads to inflammation of the gums, 
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recession and eventually tooth loss.  There is increasing evidence that it also leads to 
systemic inflammation by either direct access of the pathological bacteria in the 
mouth to the blood circulation through bleeding during brushing or flossing (58), or 
the bacteria in the plaque biofilm actually invade the endothelial tissue and access 
the systemic circulation thus leading to an inflammatory response or exacerbating 
an already present inflammation, which in turn leads to poor diabetes control and 
worsened diabetes complications. A recent study from China examined the ability of 
porphyromonas gingivalis to invade human umbilical vein endothelial cells 
(HUVECs) and to study  it’s effect on the production of nitric oxide (NO) and on the 
expression of inducible nitric oxide synthase (iNOS) and endothelial nitric oxide 
synthase (eNOS). The study completed using electron microscopy showed that P. 
gingivalis ATCC 33277 can adhere to HUVECs by fimbriae, invade the HUVECs and 
exist in the cytoplasm and vacuoles (59). The interaction between P.gingivalis and 
HUVECs showed that P. gingivalis were adhering to the HUVECs via fimbrae, and the 
HUVECs had microvilli protruding from their surfaces and interacting with the 
fimbrae.  P. gingivalis ATCC 33277 was localized in the cytoplasm of HUVECs after 
co-incubation for 8 h. P. gingivalis ATCC 33277 was also detected within vacuoles in 
HUVECs (ref). (Figure 12) Periodontal disease and Type 2 diabetes have a two-way 
relationship (60).  People with Type 2 diabetes have an increased prevalence and 
severity of periodontal disease (61).     
 
 32 
 
Figure 12:   P. gingivalis Adheres to HUVECs via Fimbraes . Transmission 
electron micrographs demonstrating P. gingivalis invasion of EC. (A and B) BAEC 
with P. gingivalis A7436. (A) At the cell surface, bacteria appear to induce EC 
structural rearrangements consistent with an endocytic mechanism. (B) 
Internalized bacteria are found within vacuole. (C) BAEC with P. gingivalis 381. Note 
the apparent contact between microfilamentous cellular components and surface-
adhering P. gingivalis. (D) BAEC with P. gingivalis fimA mutant DPG3. Absence of 
intimate interaction between EC surface and bacteria. (E and F) FBHEC incubated 
with P. gingivalis A7436. Surface adherence (E) and engulfment in vacuole (F). 
Arrows in all panels point to P. gingivalis. Bars on each image are 0.5 m unless 
otherwise specified. Composite image was constructed with Adobe Photoshop 3.0. 
Original figure taken from (infection and Immunity Journal, 1988, 64).  
 
 
 33 
 
There is also evidence that periodontal disease can exacerbate worsening 
glycemic control in patients with Type 2 diabetes.  Inflammation is key to this two 
way relationship. Type 2 diabetes is preceded by systemic inflammation which leads 
to reducing the function of pancreatic beta-cells, their apoptosis and eventually the 
development of insulin resistance. Recent studies have showed that increased 
systemic inflammation (acute-phase and oxidative stress biomarkers) results from 
the entry of periodontal pathogens and their virulence factors into the circulation, 
providing biological plausibility for the effects of periodontitis on diabetes (62). AGE 
(Advanced Glycation End products)– RAGE (Receptor for AGEs) interactions and 
oxidative-stress-mediated pathways provide plausible mechanistic links in the 
diabetes to periodontitis direction (63). It is thought that the periodontal pathogens 
can invade endothelial cells using the fimbrae and fimbrilin like peptides, which 
associate with Toll like receptors 2 that are the most prominent type of receptors on 
the endothelial cells.(64)   A recent study done by  Boston University School of 
Medicine, studied this; they utilized 41 kDa (major) and 67 kDa (minor) fimbria 
mutants to demonstrate that major fimbria are required for efficient P. gingivalis 
invasion of human aortic endothelial cells (HAEC). The researchers used  enzyme-
linked immunosorbent assay (ELISA) to detect the presence of the proteins; ELISA 
test showed that only invasive P. gingivalis caused HAEC production of pro-
inflammatory molecules interleukin (IL)-1β, IL-8, monocyte chemoattractant 
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protein (MCP)-1, intracellular adhesion molecule (ICAM)-1, vascular cellular 
adhesion molecule (VCAM)-1 and E- selectin. The purified native forms of major and 
minor fimbria induced chemokine and adhesion molecule expression similar to 
invasive P. gingivalis, but failed to elicit IL-1β production. In addition, the major and 
minor fimbria-mediated production of MCP-1 and IL-8 was inhibited in a dose-
dependent manner by P.gingivalis lipopolysaccharide (LPS). Both P. gingivalis LPS 
and heat-killed organisms failed to stimulate HAEC. Treatment of endothelial cells 
with cytochalasin D abolished the observed pro-inflamma- tory MCP-1 and IL-8 
response to invasive P. gingivalis and both purified fimbria, but did not affect P. 
gingivalis induction of IL-1β 
Obesity 
Recent evidence has begun to emerge  that obesity might have a greater role 
in this inflammation than was previously thought.  Since obesity leads to systemic 
inflammation, it can impact the oral cavity, particularly the periodontium.  The first 
report on the relationship between obesity and periodontal disease appeared in 
1977, when Perlstein et al. found alveolar bone resorption to be greater in obese 
rats compared with non- obese rats (65). This correlation was supported by further 
evidence from studies that established a relationship between increased body mass 
index and deepened periodontal pockets (66). Recent evidence links the hip to waist 
ratio and periodontitis. Recent studies have found that central fat (belly fat) was 
associated with worse periodontitis conditions (67).  Although most evidence has 
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come from cross-sectional data, strong evidence has come recently from three 
longitudinal studies in the USA, one showing significant periodontal disease 
progression over 25 years in obese men (68) and the second, a very large study of 
36,910 health care professionals showed a significant association, even among the 
non-diabetic and never- smoking over a period of up to 20 years.(69) In a third 
study a five-year follow-up of 3,590 Japanese subjects showed evidence of a dose-
response association between BMI and periodontal disease (70) . The metabolic 
pathway of a causal relationship between obesity and periodontitis remains to be 
confirmed, but it is possible that increased secretion of inflammatory mediators may 
modify the response of the periodontal tissues to the oral environment and the 
production of excessive amounts adipokines from the adipose tissue could produce 
this effect (71) . There is evidence linking periodontal disease with metabolic 
disorder, an increasingly common loose association of abdominal obesity, abnormal 
fat metabolism, hypertension, insulin resistance, high plasma fibrinogen and 
elevated CRP (72) . Another study whose aim was to examine whether overweight 
and obesity indicators like body mass index (BMI), waist circumference (WC), and 
WC-to-height ratio, predict progression of periodontal disease in men showed that 
Body mass index and WC-to-height ratio were significantly associated with hazards 
of experiencing periodontal disease progression events regardless of periodontal 
disease indicator. Adjusted hazard ratios for periodontal disease progression were 
41–72% higher in obese men (BMI 30 kg/m2) relative to men with both normal 
weight and WC-to-height ratio (50%)  (73) . This proves that periodontal disease 
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and certain obesity related systemic illnesses are related through an inflammatory 
mechanism, with abnormal fat metabolism possibly being an important factor. (74) 
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DISCUSSION 
This paper researched the correlation between three very popular chronic 
diseases, periodontal disease, diabetes and obesity. All three of them are trending 
nowadays and more and more people are being affected by them. What is in 
common among all three of them is the impact it has on the individual, obesity 
restricts someone’s movement, causes joint and muscle pain and is also the cause of 
so many other clinical conditions. It has been established that obese people; people 
with BMI 30 or higher are at increased risk of hypercholesterolemia, high blood 
pressure, gallstones, osteoarithristis and among them is diabetes (75). This is 
because adipose tissue is not just a mere deposit of fats but it is an active endocrine 
gland that releases hormones and inflammatory cytokines into the blood 
circulation; these cytokines are called adipokines and they exacerbate an already 
present inflammatory response in the body. Diabetes is preceded by a phase of 
increased inflammation which leads to the destruction of the islet cells of Langerhan 
in the pancreas and thus leads to a decreased insulin production. Also increased 
obesity contributes to the development of diabetes through metabolic syndrome 
which leads to insulin resistance. This occurs because of the increased circulating 
FFA released from the adipose tissue, which prevent the insulin activated glucose 
uptake into the tissues and thus leads to hyperglycemia of the blood and the  further 
release of more insulin and thus the condition of insulin resistance that leads to 
diabetes if left untreated for a prolonged time. Diabetes in turn has its 
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manifestations on the body, diabetics are more prone to skin infections, eye 
infections and other complications because it leads to the development of cataracts 
and glaucoma, neuropathy and poor wound healing (76). Among its manifestations 
is periodontitis, people with diabetes are at increased risk for developing 
periodontitis, this is partly because diabetics have xerostomia a condition also 
known as dry mouth, that leads to a decreased salivary flow and thus the oral cavity 
will be more prone to ulcers and infections like tooth cavities and periodontitis. In 
addition to this, diabetes leads to thickening of blood vessels so the tissues in the 
oral cavity will not get the necessary nutrients and blood flow so they will be more 
prone to infections. Moreover, recent evidence proved that the relationship between 
diabetes and periodontitis is a two way relationship, that periodontitis might also 
lead to the development of type II DM and worsening glycemic control in diabetics 
(77) . The theory behind this is that the oral pathogens can access the systemic 
circulation either through bleeding when brushing or flossing or by special 
mechanisms.  These mechanisms include invasion of endothelial cells by fimbrae 
and fimbrillin-like peptides on their surfaces when they adhere to the walls of the 
endothelial cells they go in via endocytosis and causing an overall systemic 
inflammation which again leads to the development of diabetes and other chronic 
diseases like heart disease and atherosclerosis.  This is because when pathogens 
invade endothelial cells they produce a procoagulant effect in the blood and also 
enhance the deposition of lipids on the arterial walls which leads to the 
development of atherosclerosis. All in all, this study shows that one can not separate 
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oral health from systemic health, physicians and primary care practitioners should 
be more aware of this association and people with uncontrolled diabetes should be 
referred to a dentist to have their oral condition checked regularly due to the 
association between the two diseases. Also people who are relatively obese should 
be warned about their life style by both their dentist and primary care physician and 
should be advised to change their eating habits, to exercise more often and to lower 
their weight due to the associated systemic and oral health complications. 
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June 2008 
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Recognized by Camdridge/Edexcel University for outstanding achievement 
 
EXPERIENCE 
Mass Dental Associates                                      
Boston, Massachusetts  
Volunteer Observer/ Dental Assistant                                                                                
November 2011-present 
Sterilizing and disinfecting dental equipment in order to prepare for surgery.   
Organizing the applicable instruments for each procedure. 
Mixing filling material for impressions and restorations. 
Instructing patient on general hygiene as well as post operative care 
Taking dental x-rays. 
Making casts of teeth and mouth from impressions.  
 
University of Massachusetts Boston                       
Boston, Massachusetts    
Research Assistant with Professor Adan Colon Carmona         June 2011- July 2012                                             
The research focus was phytoremediation. Arabidopsis Thaliana is genetically 
engineered to detect the concentration of a carcinogenic (Phenanthrene) in the 
environment. Six gene pairs were identified using data mining and the threshold of 
detection for each gene pair was determined by me using the various tools of DNA 
and RNA  extraction, quantitative real time polymerase chain reaction …etc.  
   
 
SKILLS 
Efficiently manage patient care, office and laboratory duties. 
Assist office manager with patient scheduling, billing and insurance claims. 
Maintain clean, sterile and positive environments optimizing patient comfort and 
safety. 
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Built a loyal patient following; frequently requested by patients to serve as their 
dental assistant. 
Fluent in English and Arabic (Mother language) 
  
Interests 
Sewing, doing embroidery, swimming and reading  
 
